The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
People are being offered the chance to scatter their loved ones' ashes from the edge of space.
Celtic's Aleksandar Tonev has been suspended for seven matches for using "offensive, insulting and abusive language of a racist nature".
People are being encouraged to post pictures of themselves sleeping in "weird" places in a bid to raise money to tackle homelessness.